Cogent Biosciences, Inc. (COGT)
35.00
+0.33
(+0.95%)
USD |
NASDAQ |
Aug 31, 16:00
35.26
+0.26
(+0.74%)
After-Hours: 20:00
Cogent Biosciences Net Income (TTM) : -377.18M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -377.18M |
| March 31, 2026 | -354.30M |
| December 31, 2025 | -328.94M |
| September 30, 2025 | -294.37M |
| June 30, 2025 | -284.08M |
| March 31, 2025 | -269.50M |
| December 31, 2024 | -255.86M |
| September 30, 2024 | -242.30M |
| June 30, 2024 | -227.04M |
| March 31, 2024 | -212.17M |
| December 31, 2023 | -192.41M |
| September 30, 2023 | -177.66M |
| June 30, 2023 | -157.34M |
| March 31, 2023 | -148.19M |
| December 31, 2022 | -140.24M |
| September 30, 2022 | -125.54M |
| June 30, 2022 | -109.56M |
| Date | Value |
|---|---|
| March 31, 2022 | -91.18M |
| December 31, 2021 | -72.27M |
| September 30, 2021 | -58.70M |
| June 30, 2021 | -89.60M |
| March 31, 2021 | -80.44M |
| December 31, 2020 | -74.81M |
| September 30, 2020 | -61.17M |
| June 30, 2020 | -23.11M |
| March 31, 2020 | -26.24M |
| December 31, 2019 | -31.83M |
| September 30, 2019 | -42.74M |
| June 30, 2019 | -40.98M |
| March 31, 2019 | -39.49M |
| December 31, 2018 | -34.55M |
| September 30, 2018 | -32.65M |
| June 30, 2018 | -29.50M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Apogee Therapeutics, Inc. | -294.37M |
| Erasca, Inc. | -287.22M |
| Moderna, Inc. | -3.151B |
| Arrowhead Pharmaceuticals, Inc. | -272.12M |
| Oncolytics Biotech, Inc. | -30.07M |